There's a lot of interest in the um in sort of, like the petro chemical side of the world. The cost point for a lot of that stuff used to make it infeasible. You're also seeing consumer preference start to fix that riLike customers, like you have certain brands. That i think that's going to start to pull at way. I love bergers but they are not even close to a great hamburger.
First Jason explains how to deliver great investor updates & the benefits of doing them well (1:36). Then, Ginkgo Bioworks CEO Jason Kelly joins to discuss the expanding capabilities of synthetic biology (24:48), how Ginkgo is currently helping customers make products more effectively (35:58), the ethics & risks of editing DNA (51:53) & more!